Is a low serum calcium level with a 25‑hydroxyvitamin D level of 118 ng/mL clinically significant?

Yes, Low Calcium with Vitamin D of 118 ng/mL is Clinically Significant and Requires Immediate Investigation

This combination of hypocalcemia with markedly elevated vitamin D (118 ng/mL) is paradoxical and clinically significant—it suggests either vitamin D toxicity with suppressed PTH, granulomatous disease, malabsorption, hypoparathyroidism, or laboratory error, and requires urgent workup.

Why This is Concerning

The vitamin D level of 118 ng/mL exceeds the upper safety limit of 100 ng/mL established by expert consensus 1. Normally, vitamin D levels above 100 ng/mL are associated with hypercalcemia, not hypocalcemia 1. When you see low calcium despite very high vitamin D, this represents a pathological state that demands explanation.

Immediate Diagnostic Steps

Check the following labs immediately:

• Ionized calcium (to confirm true hypocalcemia, not just low albumin)
• PTH level (intact parathyroid hormone)
• Serum phosphorus
• Magnesium (hypomagnesemia causes functional hypoparathyroidism)
• 1,25-dihydroxyvitamin D (active form)
• Creatinine/eGFR (renal function)
• Albumin (to calculate corrected calcium if not already done)

Differential Diagnosis to Consider

1. Vitamin D Toxicity with Suppressed PTH

• Excessive vitamin D (>100,000 IU daily or 25(OH)D >100 ng/mL) typically causes hypercalcemia 2
• However, if PTH is completely suppressed and calcium intake is inadequate, you can paradoxically see low calcium
• Look for recent high-dose supplementation history

2. Granulomatous Disease (Sarcoidosis)

• Sarcoidosis causes elevated 1,25(OH)₂D through unregulated macrophage production 3, 2
• In sarcoidosis, 84% have low 25(OH)D, but 11% have high 1,25(OH)₂D 3
• The high 25(OH)D of 118 ng/mL makes this less likely unless patient is taking massive supplements
• Check ACE level, chest imaging if suspected

3. Hypoparathyroidism

• Post-surgical (thyroid/parathyroid surgery)
• Autoimmune
• PTH will be low or inappropriately normal
• High vitamin D level may be from aggressive supplementation attempting to correct calcium

4. Malabsorption with Calcium Deficiency

• Celiac disease, inflammatory bowel disease
• Patient may be taking high-dose vitamin D but not absorbing calcium adequately 2
• Check for GI symptoms, consider celiac panel

5. Medication Interactions

• Bisphosphonates can cause transient hypocalcemia 4
• Anticonvulsants (phenytoin, phenobarbital) increase vitamin D catabolism but wouldn't explain high levels 4
• Proton pump inhibitors/H2 blockers reduce calcium absorption 4

6. Laboratory Error

• Verify both results with repeat testing
• Ensure proper sample handling

Management Algorithm

Step 1: Assess Severity of Hypocalcemia

• Symptomatic (tetany, seizures, QT prolongation): IV calcium gluconate immediately
• Asymptomatic: Proceed with workup while initiating oral calcium

Step 2: Stop All Vitamin D Supplementation

• At 118 ng/mL, this is above the safety threshold 1
• Discontinue until 25(OH)D falls below 100 ng/mL

Step 3: Based on PTH Results

If PTH is LOW (<15 pg/mL):

• Diagnosis: Hypoparathyroidism (primary or vitamin D toxicity-induced)
• Check magnesium (correct if <1.8 mg/dL)
• Start calcium carbonate 1000-1500 mg elemental calcium TID with meals 4
• Start calcitriol 0.25-0.5 mcg twice daily (active vitamin D, bypasses need for PTH)
• Monitor calcium weekly until stable

If PTH is HIGH (>65 pg/mL):

• Diagnosis: Secondary hyperparathyroidism with calcium malabsorption or vitamin D resistance
• Increase calcium supplementation to 1500-2000 mg elemental calcium daily in divided doses 4
• Check for celiac disease, consider GI evaluation
• Recheck 25(OH)D in 3 months—should decline naturally

If PTH is NORMAL (15-65 pg/mL):

• This is inappropriate for hypocalcemia
• Consider functional hypoparathyroidism
• Check magnesium, correct if low
• Treat as hypoparathyroidism if magnesium normal

Step 4: Monitor Calcium Metabolism

• Recheck corrected calcium, phosphorus, and PTH in 1 month 5, 6
• Recheck 25(OH)D in 3 months 5
• Target calcium: 8.5-10.2 mg/dL 6
• Target 25(OH)D: 30-50 ng/mL once stable 1

Critical Pitfalls to Avoid

1. Do not give more vitamin D at this level—it's already toxic range
2. Do not assume corrected calcium is accurate—always verify with ionized calcium if available
3. Do not overlook magnesium—it's required for PTH secretion and action
4. Do not use calcium carbonate alone in patients on PPIs—switch to calcium citrate 4
5. Do not forget to check medications—especially bisphosphonates, anticonvulsants, thiazides 4

When to Refer to Endocrinology

• PTH is suppressed with unclear etiology
• Hypocalcemia persists despite adequate supplementation
• Suspected granulomatous disease
• Need for long-term calcitriol management
• Vitamin D level remains >100 ng/mL after 3 months

Calcium Supplementation Specifics

Formulation choice 4:

• Calcium carbonate: 40% elemental calcium, take with food, avoid if on PPI
• Calcium citrate: 21% elemental calcium, better absorbed, can take without food, preferred if achlorhydria

Timing 4:

• Separate from thyroid hormone by 4+ hours
• Separate from bisphosphonates by 30-60 minutes
• Separate from quinolone antibiotics by several hours
• Take with meals to enhance absorption

Maximum single dose: 500-600 mg elemental calcium (absorption plateaus above this)

The paradox of high vitamin D with low calcium is never normal and always warrants thorough investigation. The most likely scenarios are vitamin D toxicity with PTH suppression, hypoparathyroidism with aggressive vitamin D supplementation, or severe malabsorption. Immediate cessation of vitamin D supplementation, calcium repletion guided by PTH levels, and identification of the underlying cause are essential.